Combination therapy is expected to play an important role for the treatment of Alzheimer’s disease (AD). In October 2018, the European Union-North American Clinical Trials in Alzheimer’s Disease Task Force (EU/US CTAD Task Force) met to discuss scientific, regulatory, and… Continue Reading →
Efforts to develop effective disease-modifying treatments for Alzheimer’s disease (AD) have mostly targeted the amyloid β (Aβ) protein; however, there has recently been increased interest in other targets including phosphorylated tau and other forms of tau. Aggregated tau appears to… Continue Reading →
In this manuscript, we have synthesized the literature reviews and meta-analyses relating to modifiable risk factors associated with AD. Article M. Rochoy (1) M. Rochoy, V. Rivas, E. Chazard, E. Decarpentry, G. Saudemont, P.-A. Hazard, F. Puisieux, S. Gautier, R…. Continue Reading →
© 2024 Aging-news